BENEVICH ERIC (Chief Commercial Officer) received a stock award from NEUROCRINE BIOSCIENCES INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/15/2026ACC: 0001643653-26-000018
Officer· Chief Commercial Officer
Since Feb 2019
+2.89K
Net shares
Net buyer
$529.0K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
6.28K acquired · 3.39K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.28K
Price / share
—
Trade value
—
% of position
9.7%
9/11/2026
64.41K→70.68K
Common Stock
Direct
Shares
−3.39K
Price / share
$156.22
Trade value
$528.96K
% of position
4.8%
9/11/2026
70.68K→67.30K
Total
Net shares
+2.89K
Net value
-$528.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2026 | A · Award | +6.28K | — | — | 9.7% | 64.41K | 70.68K |
| Common Stock Direct | 9/11/2026 | F · Tax Withholding | −3.39K | $156.22 | $528.96K | 4.8% | 70.68K | 67.30K |
| Total | +2.89K | -$528.96K | ||||||
Derivative Transactions0
No derivative transactions reported